Literature DB >> 26870297

Loss of GATA5 expression due to gene promoter methylation induces growth and colony formation of hepatocellular carcinoma cells.

Lei Xia1, Yan Gong2, Aiqun Zhang3, Shouwang Cai3, Qiang Zeng2.   

Abstract

GATA5 is a transcription factor that is capable of suppressing the development of various types of human cancer. The present study investigated the expression of GATA5 and GATA4, and examined their roles in the proliferation and colony formation ability of hepatocellular carcinoma (HCC) tissues and cells. The GATA4 and GATA5 expression levels and gene promoter methylation of HCC tissue samples from 38 patients and HCC cell lines were analyzed using reverse transcription-polymerase chain reaction (RT-PCR) and methylation-specific PCR (MSP), respectively. The effects of GATA4 and GATA5 overexpression on the proliferation and colony forming ability of HCC cells were also assessed using cell viability and colony formation assays. A luciferase reporter assay was utilized to investigate the transcriptional interaction of GATA4 and GATA5 with canonical Wnt signaling. The results indicated that the expression levels of GATA4 and GATA5 were lost or reduced following methylation of gene promoters in HCC tissues and cell lines. Treatment with a demethylating agent, 5-aza-2'-deoxycytidine (5-AZA), restored GATA4 and GATA5 expression in HCC cell lines. Furthermore, methylation of the GATA5 promoter was observed to be associated with the age of patients exhibiting HCC. Restoration of GATA4 and GATA5 expression inhibited colony formation and induced apoptosis of HCC cells in vitro. The present study concluded that the expression levels of GATA4 and GATA5 were reduced in HCC tissues and cell lines. Treatment with 5-AZA restored GATA4 and GATA5 expression in HCC cell lines, suppressing tumor cell growth and colony formation, as well as inducing apoptosis.

Entities:  

Keywords:  GATA5; cloning formation; expression; hepatocellular carcinoma; methylation; proliferation

Year:  2015        PMID: 26870297      PMCID: PMC4727174          DOI: 10.3892/ol.2015.3974

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

Review 1.  The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression.

Authors:  J D Molkentin
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

2.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

Review 3.  The GATA family (vertebrates and invertebrates).

Authors:  Roger K Patient; James D McGhee
Journal:  Curr Opin Genet Dev       Date:  2002-08       Impact factor: 5.578

4.  Wnt/beta-catenin signalling regulates cardiomyogenesis via GATA transcription factors.

Authors:  Jennifer Martin; Boni A Afouda; Stefan Hoppler
Journal:  J Anat       Date:  2010-01       Impact factor: 2.610

5.  Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation.

Authors:  X Gao; T Sedgwick; Y B Shi; T Evans
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut.

Authors:  A C Laverriere; C MacNeill; C Mueller; R E Poelmann; J B Burch; T Evans
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

Review 7.  Epigenetics and cancer treatment.

Authors:  Lasse Sommer Kristensen; Helene Myrtue Nielsen; Lise Lotte Hansen
Journal:  Eur J Pharmacol       Date:  2009-10-18       Impact factor: 4.432

8.  GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.

Authors:  Debby M E I Hellebrekers; Marjolein H F M Lentjes; Sandra M van den Bosch; Veerle Melotte; Kim A D Wouters; Kathleen L J Daenen; Kim M Smits; Yoshimitsu Akiyama; Yasuhito Yuasa; Silvia Sanduleanu; Carolina A J Khalid-de Bakker; Daisy Jonkers; Matty P Weijenberg; Joost Louwagie; Wim van Criekinge; Beatriz Carvalho; Gerrit A Meijer; Stephen B Baylin; James G Herman; Adriaan P de Bruïne; Manon van Engeland
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

9.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.

Authors:  Inga Peters; Kai Gebauer; Natalia Dubrowinskaja; Faranaz Atschekzei; Mario W Kramer; Joerg Hennenlotter; Hossein Tezval; Mahmoud Abbas; Ralph Scherer; Axel S Merseburger; Arnulf Stenzl; Markus A Kuczyk; Juergen Serth
Journal:  Oncol Rep       Date:  2014-02-18       Impact factor: 3.906

View more
  6 in total

1.  GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.

Authors:  Haipeng Feng; Mingyue Zhu; Ruizhu Zhang; Qiaoyun Wang; Wei Li; Xu Dong; Yi Chen; Yan Lu; Kun Liu; Bo Lin; Junli Guo; Mengsen Li
Journal:  J Cell Mol Med       Date:  2019-01-22       Impact factor: 5.310

2.  Overexpression of GATA5 Stimulates Paclitaxel to Inhibit Malignant Behaviors of Hepatocellular Carcinoma Cells.

Authors:  Haipeng Feng; Bo Lin; Yifei Zheng; Junnv Xu; Ying Zhou; Kun Liu; Mingyue Zhu; Mengsen Li
Journal:  Cell J       Date:  2020-07-18       Impact factor: 2.479

3.  Overexpression of centromere protein K (CENP-K) gene in hepatocellular carcinoma promote cell proliferation by activating AKT/TP53 signal pathway.

Authors:  Haiyan Wang; Weilong Liu; Lei Liu; Chi Wu; Weigang Wu; Juan Zheng; Mingxia Zhang; Xinchun Chen; Boping Zhou; Zhiliang Gao; Jian Huang
Journal:  Oncotarget       Date:  2017-05-25

4.  GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells.

Authors:  Jiaolin Liu; Fanlu Lin; Xin Wang; Chaopeng Li; Qiangyuan Qi
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  GATA4 inhibits cell differentiation and proliferation in pancreatic cancer.

Authors:  Yan Gong; Liang Zhang; Aiqun Zhang; Xin Chen; Peng Gao; Qiang Zeng
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

6.  GATA binding protein 5 (GATA5) induces Rho GTPase activating protein 9 (ARHGAP9) to inhibit the malignant process of lung adenocarcinoma cells.

Authors:  Wenfei Ji; Lili Zhang; Hongjun Zhu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.